Two-year analysis of the Japanese cohort from the Zilver PTX randomized controlled trial supports the validity of multinational clinical trials
Takao Ohki, Hiroyoshi Yokoi, Kimihiko Kichikawa, Takeshi Kimura, Scott A. Snyder, Anthony O. Ragheb, Erin E. O'Leary, Michael R. Jaff, Gary M. Ansel, Michael D. Dake
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Two-year analysis of the Japanese cohort from the Zilver PTX randomized controlled trial supports the validity of multinational clinical trials'. Together they form a unique fingerprint.